Poly Medicure Share Price
Start SIP in Poly Medicure
Start SIPPoly Medicure Performance
Day Range
- Low 2,383
- High 2,453
52 Week Range
- Low 1,250
- High 2,687
- Open Price2,449
- Previous Close2,449
- Volume125088
Poly Medicure Investment Rating
-
Master Rating:
-
Poly Medicure has an operating revenue of Rs. 1,439.74 Cr. on a trailing 12-month basis. An annual revenue growth of 25% is outstanding, Pre-tax margin of 25% is great, ROE of 17% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 13% and 39% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 9% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 85 which is a GOOD score indicating consistency in earnings, a RS Rating of 73 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 19 indicates it belongs to a strong industry group of Medical-Systems/Equip and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 367 | 361 | 321 | 320 | 306 | 293 |
| Operating Expenses Qtr Cr | 266 | 264 | 236 | 237 | 220 | 212 |
| Operating Profit Qtr Cr | 101 | 97 | 84 | 83 | 85 | 82 |
| Depreciation Qtr Cr | 19 | 16 | 16 | 15 | 15 | 15 |
| Interest Qtr Cr | 3 | 3 | 3 | 2 | 2 | 2 |
| Tax Qtr Cr | 24 | 23 | 21 | 19 | 20 | 16 |
| Net Profit Qtr Cr | 72 | 71 | 61 | 59 | 61 | 57 |
Poly Medicure Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 11
- Bearish Moving Average
- ___
- 5
- 20 Day
- ₹2,392.83
- 50 Day
- ₹2,209.17
- 100 Day
- ₹2,032.86
- 200 Day
- ₹1,818.52
- 20 Day
- ₹2,408.49
- 50 Day
- ₹2,162.19
- 100 Day
- ₹1,983.88
- 200 Day
- ₹1,756.67
Poly Medicure Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 2,458.87 |
| Second Resistance | 2,491.38 |
| Third Resistance | 2,529.37 |
| RSI | 58.64 |
| MFI | 65.34 |
| MACD Single Line | 125.94 |
| MACD | 112.68 |
| Support | |
|---|---|
| First Support | 2,388.37 |
| Second Support | 2,350.38 |
| Third Supoort | 2,317.87 |
Poly Medicure Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 126,735 | 7,985,572 | 63.01 |
| Week | 118,306 | 7,676,876 | 64.89 |
| 1 Month | 216,039 | 10,276,973 | 47.57 |
| 6 Month | 140,016 | 8,202,116 | 58.58 |
Poly Medicure Result Highlights
Poly Medicure Synopsis
NSE-Medical-Systems/Equip
Poly Medicure Lt is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 1068.05 Cr. and Equity Capital is Rs. 47.97 Cr. for the Year ended 31/03/2023. Poly Medicure Ltd. is a Public Limited Listed company incorporated on 30/03/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L40300DL1995PLC066923 and registration number is 066923.| Market Cap | 23,507 |
| Sales | 1,369 |
| Shares in Float | 3.55 |
| No of funds | 162 |
| Yield | 0.12 |
| Book Value | 16.12 |
| U/D Vol ratio | 2.3 |
| LTDebt / Equity | 1 |
| Alpha | 0.14 |
| Beta | 0.77 |
Poly Medicure Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 66.03% | 53.15% | 53.16% | 53.16% |
| Mutual Funds | 6.29% | 4.99% | 4.18% | 3.95% |
| Insurance Companies | 2.31% | 2.01% | 1.11% | 0.99% |
| Foreign Portfolio Investors | 9.91% | 12.37% | 14.1% | 14.49% |
| Individual Investors | 11.37% | 11.34% | 11.38% | 11.35% |
| Others | 4.09% | 16.14% | 16.07% | 16.06% |
Poly Medicure Management
| Name | Designation |
|---|---|
| Mr. Devendra Raj Mehta | Chairman |
| Mr. Himanshu Baid | Managing Director |
| Mr. Rishi Baid | Joint Managing Director |
| Mr. Jugal Kishore Baid | Non Executive Director |
| Mrs. Mukulika Baid | Non Executive Director |
| Mr. Alessandro Balboni | Non Executive Director |
| Mr. Prakash Chand Surana | Ind. Non-Executive Director |
| Dr. Shailendra Raj Mehta | Ind. Non-Executive Director |
| Dr. Ambrish Mithal | Ind. Non-Executive Director |
| Dr. Sandeep Bhargava | Ind. Non-Executive Director |
| Mr. Amit Khosla | Ind. Non-Executive Director |
| Ms. Sonal Mattoo | Ind. Non-Executive Director |
Poly Medicure Forecast
Price Estimates
Poly Medicure Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-07-22 | Quarterly Results | |
| 2024-06-29 | Others | Inter alia, to consider and finalize the terms and condition and approve the modes of fund raising. per share(40%)Interim Dividend |
| 2024-05-17 | Audited Results & Final Dividend | |
| 2024-03-08 | Others | Inter alia, to consider a) Business Plan for Financial Year 2024-25. b) To consider and evaluate a proposal for raising of funds, in one or more tranches, through permissible mode(s). per share(40%)Interim Dividend |
| 2024-01-31 | Quarterly Results |
Poly Medicure FAQs
What is Share Price of Poly Medicure ?
Poly Medicure share price is ₹2,426 As on 18 September, 2024 | 02:32
What is the Market Cap of Poly Medicure ?
The Market Cap of Poly Medicure is ₹23285.9 Cr As on 18 September, 2024 | 02:32
What is the P/E ratio of Poly Medicure ?
The P/E ratio of Poly Medicure is 86.4 As on 18 September, 2024 | 02:32
What is the PB ratio of Poly Medicure ?
The PB ratio of Poly Medicure is 15.8 As on 18 September, 2024 | 02:32